Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.6% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BORN
2701
DELISTED
China New Borun Corporation
BORN
| $716K | ﹤0.01% |
487,300
+46,000
| +10% | +$71.6K |
|
2702
Columbus McKinnon
CMCO
$422M
| $715K | ﹤0.01% |
40,085
+9,900
| +33% | +$166K |
|
2703
Calumet Specialty Products
CLMT
$3.7B
| $710K | ﹤0.01% |
+157,400
| New | +$810K |
|
2704
Kodak
KODK
$809M
| $707K | ﹤0.01% |
47,100
+24,800
| +111% | +$393K |
|
|
MRTX
2705
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $706K | ﹤0.01% |
106,800
-128,920
| -55% | -$686K |
|
2706
EVI Industries
EVI
$195M
| $703K | ﹤0.01% |
86,400
-700
| -0.8% | -$3.48K |
|
|
HTM
2707
DELISTED
U.S. Geothermal Inc.
HTM
| $701K | ﹤0.01% |
161,267
+27,309
| +20% | +$128K |
|
|
PSG
2708
DELISTED
Performance Sports Group Ltd.
PSG
| $701K | ﹤0.01% |
172,653
+100,053
| +138% | +$311K |
|
|
SWIR
2709
DELISTED
Sierra Wireless
SWIR
| $699K | ﹤0.01% |
+48,484
| New | +$748K |
|
|
ERF
2710
DELISTED
Enerplus Corporation
ERF
| $698K | ﹤0.01% |
108,857
-360,800
| -77% | -$2.36M |
|
2711
Regions Financial
RF
$26.4B
| $692K | ﹤0.01% |
70,121
-3,079,753
| -98% | -$28.8M |
|
2712
Selective Insurance
SIGI
$5.76B
| $690K | ﹤0.01% |
17,300
-89,600
| -84% | -$3.52M |
|
2713
Destination XL Group
DXLG
$32.9M
| $689K | ﹤0.01% |
159,100
-18,800
| -11% | -$91.6K |
|
2714
Adecoagro
AGRO
$1.4B
| $687K | ﹤0.01% |
60,200
-1,177,000
| -95% | -$12.4M |
|
|
SIEN
2715
DELISTED
Sientra, Inc.
SIEN
| $681K | ﹤0.01% |
+7,580
| New | +$588K |
|
|
MATN
2716
DELISTED
Mateon Therapeutics, Inc.
MATN
| $679K | ﹤0.01% |
1,094,900
+49,100
| +5% | +$33.3K |
|
|
WHLR
2717
Wheeler Real Estate Investment Trust
WHLR
$869K
| – | – |
0
| – | – |
|
|
GI
2718
DELISTED
EndoChoice Holdings, Inc.
GI
| $678K | ﹤0.01% |
84,900
-26,100
| -24% | -$122K |
|
|
PACD
2719
DELISTED
Pacific Drilling S A
PACD
| $678K | ﹤0.01% |
166,890
+44,900
| +37% | +$207K |
|
|
GZT
2720
DELISTED
Gazit-globe Ltd
GZT
| $676K | ﹤0.01% |
64,626
+5,226
| +9% | +$51.9K |
|
2721
Workiva
WK
$3.45B
| $674K | ﹤0.01% |
37,200
-20,600
| -36% | -$334K |
|
2722
First US Bancshares
FUSB
$91.9M
| $672K | ﹤0.01% |
63,500
+3,800
| +6% | +$35.6K |
|
2723
Madrigal Pharmaceuticals
MDGL
$12.6B
| $672K | ﹤0.01% |
52,987
-3,187
| -6% | -$30.9K |
|
|
IRD
2724
Opus Genetics
IRD
$287M
| $672K | ﹤0.01% |
6,671
+1,764
| +36% | +$213K |
|
2725
Duluth Holdings
DLTH
$152M
| $671K | ﹤0.01% |
25,300
+11,200
| +79% | +$306K |
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 414 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.